Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Jun 16:e222696. Online ahead of print. doi: 10.1001/jamaoncol.2022.2696

Errors in Author Affiliations and Figure 2

PMCID: PMC9204611  PMID: 35708718

In the Original Investigation titled “Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality,” the affiliation for Andrea Discacciati (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden) was missing. Additionally, there were errors in the y-axis scale of Figure 2A. This article was corrected online.

References

  • 1.Björnebo L, Nordström T, Discacciati A, et al. Association of 5α-reductase inhibitors with prostate cancer mortality. JAMA Oncol. Published online May 19, 2022. doi: 10.1001/jamadermatol.2022.1501 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES